208 related articles for article (PubMed ID: 21910729)
81. Interleukin-13 Pathway Alterations Impair Invariant Natural Killer T-Cell-Mediated Regulation of Effector T Cells in Type 1 Diabetes.
Usero L; Sánchez A; Pizarro E; Xufré C; Martí M; Jaraquemada D; Roura-Mir C
Diabetes; 2016 Aug; 65(8):2356-66. PubMed ID: 27207542
[TBL] [Abstract][Full Text] [Related]
82. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
83. Increased iNKT17 Cell Frequency in the Intestine of Non-Obese Diabetic Mice Correlates With High
De Giorgi L; Sorini C; Cosorich I; Ferrarese R; Canducci F; Falcone M
Front Immunol; 2018; 9():1752. PubMed ID: 30105027
[TBL] [Abstract][Full Text] [Related]
84. Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator.
Forestier C; Takaki T; Molano A; Im JS; Baine I; Jerud ES; Illarionov P; Ndonye R; Howell AR; Santamaria P; Besra GS; Dilorenzo TP; Porcelli SA
J Immunol; 2007 Feb; 178(3):1415-25. PubMed ID: 17237389
[TBL] [Abstract][Full Text] [Related]
85. Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice.
Chen PG; Hu HG; Sun ZY; Li QQ; Zhang BD; Wu JJ; Li WH; Zhao YF; Chen YX; Li YM
Mol Pharm; 2020 Feb; 17(2):417-425. PubMed ID: 31841011
[TBL] [Abstract][Full Text] [Related]
86. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
[TBL] [Abstract][Full Text] [Related]
87. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
[TBL] [Abstract][Full Text] [Related]
88. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
[TBL] [Abstract][Full Text] [Related]
89. α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.
Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
J Biol Chem; 2019 Apr; 294(14):5438-5455. PubMed ID: 30745361
[TBL] [Abstract][Full Text] [Related]
90. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
[TBL] [Abstract][Full Text] [Related]
91. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.
Smyth MJ; Wallace ME; Nutt SL; Yagita H; Godfrey DI; Hayakawa Y
J Exp Med; 2005 Jun; 201(12):1973-85. PubMed ID: 15967825
[TBL] [Abstract][Full Text] [Related]
92. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.
Trujillo-Ocampo A; Cho HW; Herrmann AC; Ruiz-Vazquez W; Thornton AB; He H; Li D; Qazilbash MA; Ma Q; Porcelli SA; Shpall EJ; Molldrem J; Im JS
Cytotherapy; 2018 Aug; 20(8):1089-1101. PubMed ID: 30076070
[TBL] [Abstract][Full Text] [Related]
93. GPR41 deficiency aggravates type 1 diabetes in streptozotocin-treated mice by promoting dendritic cell maturation.
Li JH; Zhang M; Zhang ZD; Pan XH; Pan LL; Sun J
Acta Pharmacol Sin; 2024 Jul; 45(7):1466-1476. PubMed ID: 38514862
[TBL] [Abstract][Full Text] [Related]
94. Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages.
Ghazarian L; Diana J; Beaudoin L; Larsson PG; Puri RK; van Rooijen N; Flodström-Tullberg M; Lehuen A
Diabetes; 2013 Nov; 62(11):3785-96. PubMed ID: 23894189
[TBL] [Abstract][Full Text] [Related]
95. Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.
O'Konek JJ; Illarionov P; Khursigara DS; Ambrosino E; Izhak L; Castillo BF; Raju R; Khalili M; Kim HY; Howell AR; Besra GS; Porcelli SA; Berzofsky JA; Terabe M
J Clin Invest; 2011 Feb; 121(2):683-94. PubMed ID: 21245578
[TBL] [Abstract][Full Text] [Related]
96. Impact of sugar stereochemistry on natural killer T cell stimulation by bacterial glycolipids.
Deng S; Mattner J; Zang Z; Bai L; Teyton L; Bendelac A; Savage PB
Org Biomol Chem; 2011 Oct; 9(22):7659-62. PubMed ID: 21927724
[TBL] [Abstract][Full Text] [Related]
97. NK cells are not required for spontaneous autoimmune diabetes in NOD mice.
Beilke JN; Meagher CT; Hosiawa K; Champsaur M; Bluestone JA; Lanier LL
PLoS One; 2012; 7(4):e36011. PubMed ID: 22558306
[TBL] [Abstract][Full Text] [Related]
98. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
Simoni Y; Diana J; Ghazarian L; Beaudoin L; Lehuen A
Clin Exp Immunol; 2013 Jan; 171(1):8-19. PubMed ID: 23199318
[TBL] [Abstract][Full Text] [Related]
99. CD38 is required for the peripheral survival of immunotolerogenic CD4+ invariant NK T cells in nonobese diabetic mice.
Chen YG; Chen J; Osborne MA; Chapman HD; Besra GS; Porcelli SA; Leiter EH; Wilson SB; Serreze DV
J Immunol; 2006 Sep; 177(5):2939-47. PubMed ID: 16920929
[TBL] [Abstract][Full Text] [Related]
100. C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes.
Liu Z; Courtney AN; Metelitsa LS; Bittman R
Chembiochem; 2012 Aug; 13(12):1733-7. PubMed ID: 22782839
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
